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S U M M A R Y
Objectives: The clinical utility of sonication as an adjunctive diagnostic tool for the microbial diagnosis of
cardiac implantable device-associated infections (CIDAIs) was investigated.
Methods: The implants of 83 subjects were investigated, 15 with a CIDAI and 68 without a clinical
infection. Clinical data were analyzed prospectively and sonication ﬂuid cultures (83 patients, 100%) and
traditional cultures (31 patients, 37.4%) were performed
Results: Generator pocket infection and device-related endocarditis were found in 13 (86.7%) and four
(26.7%) subjects, respectively. The mean numbers of previous technical complications and infections
were higher in the infected patients compared to the non-infected patients (8 vs. 1, p < 0.001; 2 vs. 0,
p < 0.031, respectively). The sensitivity and speciﬁcity for detecting CIDAI was 73.3% (11/15) and 48.5%
(33/68) for sonication ﬂuid culture, and 26.7% (4/15) and 100% (16/16) for traditional culture (p < 0.001),
respectively. A higher number of organisms were identiﬁed by sonication ﬂuid than by tissue culture
(58 vs. 4 specimens; p < 0.001). The most frequent organisms cultured were Gram-positive cocci (66.1%),
mainly coagulase-negative staphylococci (35.5%). Thirty-ﬁve (51.5%) non-infected subjects were
considered colonized due to the positive identiﬁcation of organisms exclusively through sonication ﬂuid
culture.
Conclusions: Sonication ﬂuid culture from the removed cardiac implants has the potential to improve the
microbiological diagnosis of CIDAIs.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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The surgical implantation of cardiovascular electronic devices,
including permanent pacemakers (PPMs), implantable cardiover-
ter deﬁbrillators (ICDs), and cardiac resynchronization devices
(CRTDs), has been indicated increasingly worldwide in the last
30 years for the treatment of many different medical conditions,
such as bradycardia, ventricular arrhythmia, and heart failure, and
for the prevention of sudden cardiac death.1–3 Indeed, data
collected in 2009 from 61 different countries have shown a* Corresponding author. Tel.: +5511-21767700; fax: +5511-21146363.
E-mail address: mcsalles@osite.com.br (M.J.C. Salles).
http://dx.doi.org/10.1016/j.ijid.2015.07.018
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).continuous rise in the number of cardiac implantable electronic
devices (CIEDs) being inserted worldwide, with the highest
number of implanted PPMs in the USA (225 567) and Germany
accounting for 927 new implants per million population.4
Although infection following CIED use remains relatively
uncommon, it may affect exclusively the generator pocket, intra-
vascular electrode components, or endocardial structures, or may
even present in different combinations, making the clinical
suspicion often delayed and not considered.5 Moreover, accurate
and evidence-based diagnostic tools for CIED-associated infections
(CIDAIs) are lacking, as the clinical presentation is highly variable,
echocardiography may show low accuracy, and blood and conven-
tional cultures of peri-implant ﬂuid (swab) or tissue samples may
show low sensitivity.6–10 False-negative microbiological resultsciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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antibiotic use and to the nature of a bioﬁlm-associated infection in
which organisms are enclosed in a polymeric matrix substance
exhibiting altered phenotype and gene expression.5,11-12 Further-
more, local positive cultures in subjects showing no signs or
symptoms of active infection have been associated with microbial
colonization of the generator pocket.13–15
A few studies have recently suggested that by using techniques
that dislodge bacterial cells from the bioﬁlm, such as vortexing and
sonication, microbial diagnosis is increased among CIDAI sub-
jects.6,13,16 Compared to conventional cultures, sonication has
shown higher sensitivity and speciﬁcity for microbial diagnosis for
a variety of implant-associated infections.17–19 In the present
study, the clinical utility of sonication as an adjunctive diagnostic
tool for CIDAIs was investigated, by comparing it with traditional
cultures (blood cultures and intraoperative peri-implant tissue
cultures). Furthermore, the utility of sonication in identifying
microbial colonization of the generator pocket was also assessed
among subjects with no signs of infection.
2. Materials and methods
2.1. Study population
Eighty-three subjects who underwent complete or partial
surgical removal of a CIED (including PPMs and ICDs) for any
reason, between September 2010 and October 2013, at the Cardiac
Surgery Unit of Santa Casa de Sao Paulo School of Medical Sciences,
Sa˜o Paulo (Brazil), were included prospectively in this study.
Subjects were excluded if clinical data were unavailable for
analysis, when the retrieved CIED was not submitted to the
sonication technique, or when contamination occurred during
implant removal, transportation, or processing in the microbiology
laboratory. Subject demographics, the type of CIED, comorbidities,
previous CIDAIs and surgeries, the length of time between
implantation and implant retrieval, clinical signs and symptoms
of infection, and the presence of endocarditis were recorded. The
study protocol was reviewed and approved by the institutional
review board.
2.2. Diagnosis of CIED-associated infection
Clinical features of CIDAI were considered to be present when
the generator pocket showed localized cellulitis, swelling, dis-
charge, wound dehiscence, or local pain; intraoperative tissue
showed visible purulence as determined by the surgeon; a draining
ﬁstula communicating with the internal implant was evident; and
when signs and symptoms of systemic infection (fever, chills, night
sweats, malaise) were present. The Duke criteria were also used for
the diagnosis of CIED infective endocarditis.20–21
2.3. Specimen collection and microbiological methods
In the surgical ward, blood cultures, sterile cotton swabs of the
prosthetic (generator and leads), peri-prosthetic ﬂuids, and tissue
samples were collected and processed for microbiology and
histopathology. Tissue was homogenized in 3 ml of brain–heart
infusion (BHI) broth for 1 min. Homogenized tissue and wood shaft
cotton swabs were inoculated onto aerobic sheep blood agar,
chocolate agar, and anaerobic blood agar and into thioglycolate
broth (BD Diagnostic Systems, Sparks, MD, USA). The time limit for
processing samples was 6 h. Aerobic and anaerobic plates were
incubated aerobically at 35–37 8C in 5–7% CO2 for 7 days and
anaerobically at 37 8C for 14 days, respectively. Additionally, 0.5 ml
of tissue homogenate was inoculated in thioglycolate broth,
incubated for 14 days, and the turbid thioglycolate broth wassub-cultured on blood agar plates when cloudy. Colonies of
microorganisms growing on plates were identiﬁed, and their
susceptibility to antibiotics was tested by standard microbiological
techniques. Bacterial identiﬁcation was performed with routines
established in the laboratory, assessing the morphology and
tinctorial properties displayed on Gram staining. Catalase tests
were applied on Gram-positive colonies to identify Staphylococcus
spp and Streptococcus spp. DNase tests differentiated Staphylococcus
aureus from coagulase-negative staphylococci (CoNS), while groups
of Streptococcus spp and Enterococcus spp were identiﬁed by their
hemolysis (alpha, beta, or gamma), ability to hydrolyze esculin in the
presence of bile, and growth on 6.5% NaCl associated with
susceptibility testing to optochin and bacitracin or the CAMP test,
when necessary. Gram-negative colonies were identiﬁed by
biochemical methods to determine their genus and species,
including glucose non-fermenting bacteria. Low-virulence micro-
organisms (CoNS, Corynebacterium sp, Chryseobacterium sp, Bacillus
sp) were considered pathogens when the same organism was
identiﬁed in at least two different tissue samples, or when at least
one additional (culture-independent) criterion for CIDAI was also
fulﬁlled.
2.4. CIED sonication
In the operating room, the explanted CIEDs were removed
aseptically and placed in sterilized solid polyethylene containers,
to which 250 ml of Ringer solution was added; these were sealed
with an air-tight cover. In the microbiology laboratory, containers
with the retrieved implants were vortexed for 30 s using a Vortex-
Genie 2 (Scientiﬁc Industries Inc., Bohemia, NY, USA) and then
sonicated (ultrasound bath BactoSonic; Bandelin GmbH, Berlin,
Germany) for 5 min at a frequency of 40  2 kHz and power density
0.22  0.04 W/cm2, followed by an additional 30 s of vortexing, in
accordance with the technique of Trampuz et al.17 To concentrate the
resulting sonication ﬂuid, centrifugation was performed in 50-ml
aliquots at 2500 rpm for 5 min. The supernatant was aspirated,
leaving 0.5 ml (100-fold concentration), and aliquots of 0.1 ml of
concentrated sonication ﬂuid were then plated onto aerobic sheep
blood, chocolate, and anaerobic sheep blood agar; these were
incubated aerobically at 37 8C for 7 days and anaerobically at 37 8C
for 14 days, respectively, and inspected daily for bacterial growth.
Additionally, 4 ml of the remaining concentrated sonication ﬂuid was
inoculated in 10 ml thioglycolate broth, plated as described above,
and incubated aerobically at 35–37 8C in 5% CO2 for 2 days and
anaerobically at 37 8C for 14 days. A 4-ml aliquot of sonication ﬂuid
and all the detected organisms were frozen at 70 8C. Colonies of
isolated microorganisms growing on plates were quantitated
(number of colony-forming units per milliliter sonication ﬂuid;
CFU/ml), identiﬁed, and their antimicrobial susceptibility was tested
using standard microbiological techniques. Due to the addition of a
concentration step to the sonication ﬂuid culture, a cut-off of 50 CFU/
plate was considered positive and used for ideal sensitivity and
speciﬁcity analysis.19 Furthermore, for those subjects on antimicro-
bial therapy or those who had previously received antibiotics for at
least 24 h in the 14 days prior to surgery, any growth of organism in
the sonication ﬂuid culture was considered positive. CIEDs explanted
due to aseptic reasons were used as negative controls and processed
in the same manner as described for the infected CIED implants
retrieved.
2.5. Statistical analysis
Characteristics of subjects with infected and non-infected
cardiovascular electronic devices were summarized as the
frequency and percentage, or as the mean (range) and standard
deviation (SD). Descriptive comparisons between categorical
R.C. Inacio et al. / International Journal of Infectious Diseases 38 (2015) 54–5956variables were performed using the Chi-square test or Fisher’s
exact test, as appropriate. Continuous variables were compared
with the Student t-test (normally distributed) or Mann–Whitney
U-test (non-normally distributed). Sensitivities, speciﬁcities,
positive predictive values, and negative predictive values were
compared between tissue culture and sonication ﬂuid culture
using the McNemar test of paired proportions. Ninety-ﬁve percent
conﬁdence intervals (CIs) were calculated as exact binominal
conﬁdence intervals. Differences were considered signiﬁcant when
the p-value was <0.05 (two-tailed). Data were analyzed using IBM
SPSS Statistics for Windows version 19.0 (IBM Corp., Armonk, NY,
USA).
3. Results
3.1. Study population and devices
Eighty-ﬁve CIEDs from 85 subjects were retrieved consecutively.
Two of the subjects were excluded from further analysis, one
because a removed implant was not cultured and the second due to
clear contamination being detected during implant removal. In total,
83 implants were analyzed: 72 (86.7%) were PPMs and 11 (13.3%)
were ICDs. Among these, CIDAIs were diagnosed clinically in
15 subjects (18.1%) and non-infected-CIDs (NICIDs) were found in 68
(81.9%) subjects. Generator pocket infection and device-related
endocarditis were found in 13 (86.7%) and four (26.7%) subjects,
respectively. Demographic parameters and clinical characteristics of
the study population are shown in Table 1.
The clinical presentation of the 15 subjects diagnosed with a
CIDAI included signs and symptoms of pocket inﬂammation, such
as pocket erythema (86.7%), swelling (66.7%), pus (60%), local pain
(53.3%), and warmth (53.3%), and the presence of systemic signs
such as fever (53.3%) and chills (26.7%). Only one patient (6.7%)
presented septic shock associated with the cardiac implant
infection. The median age of the implants at the time of resection
surgery was lower in the CIDAI group than in the NICID group
(24 vs. 84 months, respectively; p < 0.001). The mean numbers ofTable 1
Characteristics of 83 subjects with cardiac implantable device-associated infections
(CIDAI) and non-infected cardiac implantable devices (NICID)
Subjects with
CIDAI (n = 15)
Subjects with
NICID (n = 68)
p-Valuea
Demographic characteristicsb
Male sex, n (%) 7 (46.6%) 27 (39.7%) 0.620
Age, years, median (range) 60 (40–90) 66.5 (32–95) 0.596
Duration of CIED use, months,
median (range)
24 (1–168) 84 (12–324) <0.001
Clinical characteristics, n (%)
Diabetes mellitus 3 (15%) 11 (16.2%) 0.711
Coronary diseases 4 (26.7%) 14 (20.6%) 0.730
Heart failure 9 (60%) 48 (61.8%) 0.899
Chagas disease 4 (26.7%) 15 (22.1%) 0.738
Chronic renal failure 1 (6.7%) 2 (2.9%) 0.455
Smoking 3 (15%) 4 (5.9%) 0.107
More than one revision 6 (40%) 12 (17.6%) 0.057
Previous CIED complications 8 (53.3%) 1 (1.5%) <0.001
Previous CIED infections 2 (13.3%) 0 (0%) 0.031
Prior use of antimicrobialsc 13 (86.7%) 0 (0%) <0.001
CIED, cardiac implantable electronic device.
a Patient characteristics were summarized as the frequency and percentage, or as
the median and range, and were compared using the Pearson Chi-square test or
Fisher’s exact test as appropriate for nominal variables and the Mann–Whitney test
or t-test as appropriate for continuous variables (IBM SPSS software, version 19.0).
All tests were two-sided and a p-value of <0.05 was considered statistically
signiﬁcant.
b All percentages are in relation to the number of subjects with CIDAI or NICID
unless indicated otherwise.
c Patients who received a minimum of 1 day of antibiotic therapy within the
14 days prior to removal of the implants.previous technical complications and infections associated with
CIEDs were higher in the CIDAI group than in the NICID group (8 vs.
1, p < 0.001; 2 vs. 0, p < 0.031, respectively). The groups were
similar with regard to comorbidities (Table 1).
3.2. Microbiology
Sonication ﬂuid cultures and swab/tissue/blood cultures were
performed for 83 (100%) and 31 (37.4%) subjects, respectively. For
subjects with a NICID, sonication ﬂuid cultures and swab/tissue/
blood cultures were collected for 68 (100%) and 16 (23.5%),
respectively. Higher numbers of microorganisms were identiﬁed
by sonication ﬂuid culture of explanted CIEDs than by peri-
implant tissue and blood cultures (58 vs. 4 specimens; p < 0.001).
Twelve (80%) subjects with a CIDAI received a deﬁnitive microbial
diagnosis through a combination of sonication of explanted
devices and tissue/blood cultures. On the other hand, tissue/blood
culture identiﬁed bacteria but not sonication ﬂuid culture in only
one (6.7%) infected patient. Conversely, sonication ﬂuid culture
was the only source of pathogen identiﬁcation for eight (72.7%)
CIDAI subjects. Indeed, tissue and blood culture were able to
detect only four Gram-negative bacilli (Escherichia coli, Enter-
obacter sp, Klebsiella pneumoniae, Morganella morgannii) but no
Gram-positive cocci among four subjects with CIDAIs, and no
pathogens were detected among 16 subjects with NICIDs.
Sonication ﬂuid cultures yielded a signiﬁcantly higher rate of
pathogen detection among 11 subjects with CIDAI, but also in
35 subjects with NICID (with no clinical diagnosis of infection), a
result that was considered to indicate colonization. From
sonication ﬂuid of explanted CIDs, the most frequent organisms
cultured were Gram-positive cocci (66.1%), of which CoNS was
identiﬁed in 35.5%, followed by Streptococcus spp in 14.5% and S.
aureus in 9.8%, whereas Gram-negative bacilli were cultured
in 27.4%. Peculiar bioﬁlm-forming pathogens such as Stenotro-
phomonas maltophilia, Corynebacterium sp, Acinetobacter bauman-
nii, Pseudomonas sp, and Candida sp, were also identiﬁed. A
polymicrobial infection was diagnosed in only one patient (S.
aureus and CoNS detected on sonication ﬂuid culture). For three
(20%) subjects with CIDAIs, bacterial isolation was not possible
with either sonication ﬂuid or tissue/blood culture. Table 2
summarizes the microorganisms identiﬁed in sonication ﬂuid
cultures and tissue/blood cultures among 83 subjects with CIDAI
and NICID (colonized).Table 2
Distribution of microorganisms detected by sonication ﬂuid culture and tissue/
blood culture among the 83 subjects included in the study
Microorganism Sonication
culture
(n = 83)
Tissue/blood
culture
(n = 31)
n % n %
CoNS 22 26.5 0 0
Staphylococcus aureus 6 7.2 0 0
Streptococcus sp 9 10.8 0 0
Micrococcus sp 2 2.4 0 0
Bacillus sp 1 1.2 0 0
Acinetobacter baumannii 3 3.6 0 0
Stenotrophomonas maltophilia 3 3.6 0 0
Klebsiella pneumoniae 3 3.6 1 3.2
Enterobacter sp 2 2.4 1 3.2
Pseudomonas sp 2 2.4 0 0
Escherichia coli 1 1.2 1 3.2
Morganella morgannii 0 0 1 3.2
Corynebacterium sp 1 1.2 0 0
Chryseobacterium indologenes 2 2.4 0 0
Candida albicans 1 1.2 0 0
CoNS, coagulase-negative Staphylococcus.
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between sonication ﬂuid and tissue/blood cultures
Forty-six subjects (55.4%) had positive sonication ﬂuid cultures
(11 CIDAI and 35 NICID), and only four (4.8%) presented positive
tissue cultures (4 CIDAI and 0 NICID) (p < 0.001). The sensitivity of
sonication ﬂuid culture for microbiological diagnosis among 15 sub-
jects with CIDAI was higher than tissue/blood culture (73.3% vs.
26.7%, respectively; p < 0.001). Conversely, the speciﬁcity showed
signiﬁcantly better results for tissue/blood culture than sonication
ﬂuid culture, at 100% and 48.5%, respectively (p < 0.001). Positive and
negative predictive values of tissue/blood culture and sonication
tissue culture were 100%and 23.9%, and 59.2% and 89.2%, respectively
(Table 3).
The global concordance (positive and negative results) between
the tissue and sonication ﬂuid cultures was only 51.6% (16/31).
Among the subjects with CIDAIs and NICIDs, the tissue/blood and
sonication ﬂuid cultures were concordant in 40% (6/15) and 62.5%
(10/16), respectively. There were 15 discordant results between
the sonication ﬂuid and tissue/blood cultures. Table 4 summarizes
the discordant microbiology results between the sonication ﬂuid
and tissue cultures among subjects with CIDAI and NICID.
3.4. Identiﬁcation of microorganisms in subjects presenting no clinical
signs of CIDAI
Thirty-ﬁve (51.5%) out of 68 non-infected subjects (NICID) were
considered colonized due to the positive identiﬁcation of micro-
organisms exclusively through sonication ﬂuid culture. Gram-
positive cocci accounted for 69.5% of microorganisms isolated,
mainly CoNS, which was identiﬁed in 43.5%, followed by
Streptococcus spp in 8.7%, Enterococcus sp in 8.7%, and S. aureus
in 6.5%, whereas Gram-negative bacilli were cultured in 30.5%
(mainly A. baumannii, 10%). No differences were found between
colonized and non-colonized subjects regarding demographic
parameters and clinical characteristics such as comorbidities, age
of the implant, number of past surgical revisions, previous local
complications, and antibiotic use prior to surgery, among the study
population.
3.5. Previous antimicrobial therapy
Thirteen out of 15 (86.7%) subjects with a CIDAI received at least
of 1 day of antibiotic therapy within 14 days prior to the surgical
removal of the cardiac implants, and among them, identiﬁcation ofTable 3
Comparison between sonication ﬂuid culture and tissue/blood culturea
Sensitivityb Speciﬁcityc PPV NPV
(95% CI) (95% CI) (95% CI) (95% CI)
Sonication
ﬂuid
culture
73.3 (11/15) 48.5 (33/68) 23.9 (11/46) 89.2 (33/37)
CI: 44.6–100 CI: 36.6–60.4 CI: 11.6–36.2 CI: 77.3–100
Tissue/
blood
culture
26.7 (4/15) 100 (16/16) 100 (4/4) 59.2 (16/27)
CI: 13.8–31.2 CI: 91–100 CI: 70.5–100 CI: 41.6–60.7
PPV, positive predictive value; NPV, negative predictive value; CI, conﬁdence
interval.
a Comparison among 83 subjects for whom sonication ﬂuid culture was done and
31 subjects for whom tissue/blood culture was done.
b The sensitivities of the different culture methods were compared with
McNemar’s test of paired proportions (p < 0.001).
c The speciﬁcities of the different culture methods were compared with
McNemar’s test of paired proportions (p < 0.001).organisms occurred in 30.8% (4/13) and 76.7% (10/13) of the tissue
and sonication ﬂuid cultures, respectively. Although the percent-
age of microbial identiﬁcation was higher for sonication ﬂuid
culture when compared with traditional tissue/blood culture, this
difference did not reach statistical signiﬁcance (76.7% vs. 30.8%,
p = 0.07). For the two infected subjects without previous
antibiotic use, sonication cultures identiﬁed organisms in only
one subject, while tissue cultures identiﬁed pathogens in neither
of them. None of the NICID subjects had used antibiotics before
implant removal.
4. Discussion
Interestingly, some studies have shown an increase in the rate
of CIDAIs greater than the rate of new cardiac implantable devices
inserted.4,24–25 Consequently, it is important to assure a prompt
and accurate clinical and microbial diagnosis, which will guide the
optimal treatment of the device infection. Recently published
guidelines addressing the management of CIDAIs recommend a
combination of different methods to achieve an adequate
microbial diagnosis, including culture of blood, lead tips, lead
vegetation, generator pocket tissues, and pus from the generator
pocket wound.5 Although presenting high rates of speciﬁcity,
blood culture lacks sensitivity particularly among those patients
with prior antimicrobial therapy.23,26 In the present study, at least
two sets of blood cultures were collected for all infected patients,
but few pathogens (13.3%) were identiﬁed. Because they are easy
and simple to perform, swab culture techniques have been the
preferred methodology for sample collection for many surgeons,
but frequent contamination and discordant and inferior results for
swabs and tissue cultures have been reported by some authors.8
Additionally, many studies addressing the diagnosis of implanted
device-associated infections have demonstrated that the identiﬁ-
cation of the causative microorganisms solely by tissue culture has
been unhelpful for a considerable proportion of patients, especially
among those with previous use of systemic antibiotics.6,19,27–28
Among 15 infected patients included in the present study, swab
cultures identiﬁed no pathogens and peri-implant tissue cultures
gave just two positive results (13.3%). It is important to note that
almost 90% of infected patients were on antimicrobial therapy
during the swab and tissue collection, which might partially
explain the low sensitivity of swab and tissue cultures. Indeed,
among infected subjects with previous antibiotic use, sonication
had much higher success in identifying microorganisms compared
to tissue/blood culture (76.7% vs. 30.8%), although this difference
did not reach statistical signiﬁcance, probably due to the small
sample size analyzed.
This study group has previously studied the microbiological
diagnosis of osteosynthesis-associated infections and showed the
superiority of sonication of explanted orthopedic devices over
tissue culture.19 In the present study, compared to blood/tissue
culture, sonication of CIEDs identiﬁed causative pathogens in a
signiﬁcantly higher proportion of subjects. Tissue-positive and
sonication ﬂuid culture-negative results were seen in only one
infected subject (6.7%), and among three other infected subjects
presenting positive tissue/blood cultures, sonication ﬂuid detected
the same pathogens (E. coli, M. morgannii, and K. pneumoniae). In
agreement with other authors, it is hypothesized that the reason
for the increased detection of pathogens through sonication is that
CIDAIs are typically produced by low-virulence bioﬁlm-forming
pathogens that attach to the surfaces of large stainless steel
implants such as PPMs and ICDs.6,17,19,29 Furthermore, the
explanted CIED components, including the pocket generator and
leads, were all placed together into the container, thus detaching
large amounts of bacteria from the bioﬁlm. Other researchers have
also advocated alternative techniques to swab and tissue culture
Table 4
Cardiac implantable device-associated infection (CIDAI) and non-infected cardiac implantable device (NICID) subjects with discordant results between sonication ﬂuid
culture and tissue/blood culture
Case CIDAI Tissue/blood culture Sonication ﬂuid culture NICID Tissue/blood culture Sonication ﬂuid culture
ICD 22 Yes Negative Enterobacter sp No - -
MP 30 Yes Negative Candida albicans No - -
MP 33 No - - Yes Negative Streptococcus sp
MP 36 Yes Negative S. maltophilia No - -
MP 45 No - - Yes Negative S. aureus
MP 58 Yes Negative S. aureus No - -
MP 59 Yes M. morgannii Negative No - -
ICD 60 No - - Yes Negative CoNS
MP 67 Yes Negative S. aureus + CoNS No - -
MP 68 No - - Yes Negative A. baumannii
MP 71 No - - Yes Negative K. pneumoniae
ICD 77 Yes Negative S. aureus No - -
MP 78 No - - Yes Negative S. aureus
MP 80 Yes Negative Streptococcus sp No - -
MP 83 Yes Negative CoNS No - -
CoNS, coagulase-negative Staphylococcus.
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concluded that low-intensity ultrasound applied to the retrieved
implants to dislodge microorganisms from the bioﬁlm represents a
more sensitive technique, especially in patients receiving antimi-
crobial therapy.6,13,16
Classically, Gram-positive bacteria (both CoNS and S. aureus)
have been by far the most common pathogens isolated in
CIDAIs.5,30 Not surprisingly in the present study, sonication ﬂuid
cultures of explanted CIEDs yielded mainly Gram-positive cocci
(69.5%), mostly CoNS, followed by Streptococcus spp and S. aureus;
however, other bioﬁlm-forming pathogens such as S. maltophilia,
Corynebacterium sp, A. baumannii, Pseudomonas sp, and Candida sp
were also identiﬁed. Conversely, among the infected subjects with
positive cultures (including two cases of endocarditis-associated
CIED), the spectrum of microorganisms identiﬁed was different
from that reported by other authors, in which half of the bacteria
isolated were Gram-negative bacilli, suggesting a strong inﬂuence
of previous antibiotic intake on the skin ﬂora prior to device
removal. Furthermore, subjects presenting late infections are likely
to present with non-staphylococcal organisms that may be less
frequently diagnosed in pocket infection.24–25,30
Asymptomatic bacterial colonization due to bioﬁlm formation
on the surface of CIEDs has been deﬁned as a risk factor for CIDAI,
with rates varying from 21% to 27% when phenotypic methods of
investigation were applied.13,16 Nevertheless, authors using
molecular biology methods were more successful in identifying
microorganisms colonizing uninfected CIEDs, with rates ranging
from 38.5% to 47.2%.15,22 In the present study, subjects presenting
no clinical signs or symptoms of infection had microorganisms
cultured in 51.5% of CIEDs submitted to sonication, but no growth
was seen on tissue/blood culture. Whether the isolation of
microorganisms on cardiac devices submitted to sonication
means true colonization or future clinical pocket infection, or
even simply contamination of the processes, has been the focus of
literature debate.6,13,22,24 Previous studies have demonstrated
that compared to conventional tissue culture, sonication of
infected implanted devices achieves higher rates of sensitivity,
but that speciﬁcity may be less accurate due to the nature of
bioﬁlm-associated colonization.19 This is especially true among
subjects using antibiotics, which affects bacterial growth on
tissues but not within the bioﬁlm. The most common micro-
organisms cultured in colonized subjects belonged to the
skin ﬂora, predominantly Gram-positive (69.5%), particularly
CoNS (43.5%). Previous authors have obtained similar results, in
which ubiquitous Gram-positive organisms of the skin ﬂorapredominate over other organisms.15,22 It is argued that applying
sonication routinely for every explanted cardiac device would be
costly and that it is therefore unfeasible. Nevertheless, as the
clinical signs of bioﬁlm-associated infection may be undetected,
sonication of the CIEDs may be useful to increase microbiological
diagnosis in the case of a symptomatic or even asymptomatic
subject presenting a higher risk of infection (prior CIDAI or a
higher number of previous local procedures).
Fewer non-infected subjects (23.5%) had tissue/blood cultures
performed, which might have led to bias with regard to the higher
sensitivity of sonication. This study had several other limitations,
including the relatively small sample size involved and the high
rates of chronic medical conditions such as heart failure, Chagas
diseases, and diabetes, which might have inﬂuenced the high rates
of colonization. In addition, the follow-up period was no longer
than 6 months, and it was therefore not possible to assess the real
impact of device colonization on the subsequent development of
clinical infection over time. As already stated by others, the non-
blinded collection of infected and non-infected subjects also
limited the results.13
In summary, the results of this study demonstrated that
sonication culture is superior to tissue/blood culture for the
microbial diagnosis of cardiac implantable device infections,
especially among subjects using systemic antibiotics. Since half
of all CIDAIs are caused by Gram-negative bacteria, the present
ﬁndings should prompt clinicians to choose a broad empiric
antibiotic therapy to cover Gram-positive, but also Gram-negative
bacteria, until cultures identify the causative agent(s). To be able to
better understand the epidemiology of colonized cardiac implants
in uninfected subjects and to assess the risk of subsequent
infection, sonication enables the growth of a high proportion of
latent organisms encased in the bioﬁlm.
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